Trials (Institut du Cancer de Montpellier): Revision history

From Beacon

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

3 December 2023

  • curprev 23:4323:43, 3 December 2023‎ Francine talk contribs‎ 81,685 bytes +81,685‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut du Cancer de Montpellier page '''NCTID''': NCT00875667 '''Title''': A Study to Determine the Efficacy of Lenalidomide Versus Investigator’s Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) '''Study Summary''': To evaluate the safety and efficacy of lenalidomide versus investigator choice in patients with relapsed or refractory mantle cell lymphoma. '''Sponsor''':..."
Retrieved from "https://wiki.beaconcancer.org/index.php?title=Trials_(Institut_du_Cancer_de_Montpellier)"
Powered by MediaWiki
Powered by Semantic MediaWiki